CASI Pharmaceuticals Has Entered Into An Exclusive Distribution Agreement With China National Medicines Corporation Ltd. For The Distribution Of Pralatrexate For Injection In China, Excluding Hong Kong SAR, Taiwan, And Macau, For A Period Of One Year
Benzinga Newsdesk - Dec 8, 2023, 4:28PM